日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Improving the health of the drugs industry

By Liu Jie | China Daily | Updated: 2013-04-11 10:28

Improving the health of the drugs industry

An employee at Eli Lilly and Co's China Research and Development Center. The US-based international drugmaker puts 20 percent of its sales revenue into R&D every year and set up an R&D center in Shanghai last May. [Provided to China Daily]


Eli Lilly chief Lechleiter sees China as the company's most promising market

John C. Lechleiter says he loves work and believes everyone has to find his or her own right answer about a work-life balance.

"I find it's very difficult to separate them out: That is work and this is life," said the chairman, president and chief executive officer of the world's fifth-largest biopharmaceutical company Eli Lilly and Co.

With a very supportive wife, Lechleiter said he is very conscious about getting enough sleep at night and tries to get regular exercise. All of these are because, as he said: "I try to make sure that when I need to work hard, I am able to do that."

In addition to being CEO of Lilly, he also works for industrial associations - as chairman of the Pharmaceutical Research and Manufacturers of America and president of the International Federation of Pharmaceutical Manufacturers & Associations - and on the boards of many institutes, such as the Life Sciences Foundation and the Central Indiana Corporate Partnership. Taking multiple roles, none of them easy, means Lechleiter's life is full of meetings, conferences, forums and business trips.

Challenging works

Like many innovative drug producers, Lilly has faced a tough time since 2011, with patents of the company's several blockbuster drugs expiring, leading to generic drugs sold at much lower prices booming in the market. Meanwhile, the development of new medicines has not been completed. That's a crucial threat to any pharmaceutical company that relies on research and development.

"Lilly has been clear from the very beginning: We intend to invest properly in R&D and really depend on our pipeline to help resume growth after this period (of patent expiration)," said Lechleiter, adding that the drugmaker will continue to put 20 percent of its sales revenue into R&D.

He also marked up developing and emerging markets, including China, and exploring the wider potential of current products as part of a strategy to lift the company out of these hard times.

Previous Page 1 2 3 4 5 6 Next Page

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 亚洲日本中文字幕 | 欧美精品一区二区三区久久 | 国产精品国产精品 | 亚洲乱轮视频 | 自偷自拍三级全三级视频 | 国产精品免费观看视频 | 天天操天天爱天天干 | 国产1区2区| 亚洲免费三区 | 日本黄 色 成 年 人免费观看 | 在线婷婷 | 精品久久伊人 | 国产成人一区二区三区久久久 | 日韩精品 电影一区 亚洲 | 一区二区三区国产在线 | 成人欧美一级毛片免费观看 | www.一区| 99久久精品免费看国产一区二区 | 99久久国产综合精品网成人影院 | 久久99国产精品免费网站 | 精品一本久久中文字幕 | 白色白色视频免费观看 | 日本亚洲精品色婷婷在线影院 | 国产精品自在线 | 婷婷色爱区综合五月激情韩国 | 日本在线看 | 久久久婷 | 国产免费网址 | 亚洲AV无码色情第一综合网 | 高清一区高清二区视频 | 欧美性a视频 | 中文在线一区二区 | 综合精品 | 欧美在线观看视频网站 | 涩涩天堂 | 99久久99热这里只有精品 | 玖玖精品| 成人欧美一区二区三区 | 九热在线 | 天天干视频网站 | jizz国产精品免费麻豆 |